London - Systagenix Wound Management, previously Professional Wound Care of Ethicon Inc, is a new portfolio company created by One Equity Partners to build upon its existing polyurethane wound dressing brands.
The new company will be headquartered in the UK, including a manufacturing and R&D site in Gargrave, North Yorkshire, UK. Existing personnel from R&D, sales, marketing and operations have been transferred along with all existing brand trademarks, the company said 2 Dec.
"We have inherited a business with a strong heritage and outstanding pedigree providing an excellent platform for future growth. The wound-care market represents substantial opportunity and with our investment plan, customer relationships and scientific and technical capabilities, Systagenix will become the driving force in the industry," said Systagenix ceo Steve Atkinson.
Bioclusive Select Transparent Dressings are made from thin, transparent polyurethane film. These semi-occlusive dressings provide a bacterial/viral barrier, allow oxygen vapour transfer, permit continuous observation, and feature "easy stretch" removal which helps reduce skin irritation.
Ethicon Inc, part of Johnson & Johnson, is a global medical device company that develops products for use in general surgery, wound management, and women's health.